About PacBio
PacBio is a company based in Menlo Park (United States) founded in 2004.. PacBio has raised $395 million across 11 funding rounds from investors including Morgan Stanley, Kleiner Perkins and SoftBank Group. The company has 575 employees as of December 31, 2024. PacBio has completed 2 acquisitions, including Circulomics and Omniome. PacBio operates in a competitive market with competitors including Nanopore, Omniome, Complete Genomics, QuantuMDx and Bionano, among others.
- Headquarter Menlo Park, United States
- Employees 575 as on 31 Dec, 2024
- Stage Public
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pacific Biosciences Of California, Inc.
-
Annual Revenue
$154.01 M-23.19as on Dec 31, 2024
-
Net Profit
$-309.85 M-1.02as on Dec 31, 2024
-
EBITDA
$-212.1 M23.61as on Dec 31, 2024
-
Total Equity Funding
$395 M (USD)
in 11 rounds
-
Latest Funding Round
$900 M (USD), Post-IPO
Feb 10, 2021
-
Investors
Morgan Stanley
& 20 more
-
Employee Count
575
as on Dec 31, 2024
-
Investments & Acquisitions
Circulomics
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of PacBio
PacBio is a publicly listed company on the NASDAQ with ticker symbol PACB in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of PacBio
PacBio has successfully raised a total of $395M across 11 strategic funding rounds. The most recent funding activity was a Post-IPO round of $900 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 11
- Last Round Post-IPO — $900.0M
-
First Round
First Round
(15 Jan 2007)
- Investors Count 21
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2021 | Amount | Post-IPO - PacBio | Valuation |
investors |
|
| Feb, 2013 | Amount | Debt – Conventional - PacBio | Valuation |
investors |
|
| Jul, 2010 | Amount | Series F - PacBio | Valuation | Deerfield Triarc Capital , DAG Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PacBio
PacBio has secured backing from 21 investors, including institutional and venture fund investors. Prominent investors backing the company include Morgan Stanley, Kleiner Perkins and SoftBank Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are managed in technology and healthcare sectors by this firm.
|
Founded Year | Domain | Location | |
|
Mid-stage venture capital investments and support for tech entrepreneurs.
|
Founded Year | Domain | Location | |
|
Early stage venture capital firm investing in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PacBio
PacBio has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Circulomics and Omniome. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Genome sequencing platform is provided for clinical diagnostics.
|
2013 | ||||
|
Platforms for genome profiling and biomarker analysis are developed.
|
2009 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - PacBio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pacbio Comparisons
Competitors of PacBio
PacBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, Omniome, Complete Genomics, QuantuMDx and Bionano, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Nanopore-based electronic systems for single-molecule analysis are developed.
|
|
| domain | founded_year | HQ Location |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| domain | founded_year | HQ Location |
DNA sequencing platform for human genome analysis is developed.
|
|
| domain | founded_year | HQ Location |
Handheld diagnostic and sequencing devices are developed for personalized healthcare.
|
|
| domain | founded_year | HQ Location |
Provider of genome analysis solutions to researchers and clinicians
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pacbio
Frequently Asked Questions about PacBio
When was PacBio founded?
PacBio was founded in 2004 and raised its 1st funding round 3 years after it was founded.
Where is PacBio located?
PacBio is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Who is the current CEO of PacBio?
Christian Henry is the current CEO of PacBio.
Is PacBio a funded company?
PacBio is a funded company, having raised a total of $395M across 11 funding rounds to date. The company's 1st funding round was a Series F of $109M, raised on Jan 15, 2007.
How many employees does PacBio have?
As of Dec 31, 2024, the latest employee count at PacBio is 575.
What is the annual revenue of PacBio?
Annual revenue of PacBio is $154.01M as on Dec 31, 2024.
What does PacBio do?
PacBio was founded in 2004 in Menlo Park, United States, within the biotechnology sector. Instrument systems and associated software for real-time sequencing of single molecules are developed by the company. A sequencing platform based on two proprietary technologies is utilized to enable this process. Analytical software for refining sequence data processing and generating reports is also provided, supporting operations in genomic research across the United States.
Who are the top competitors of PacBio?
PacBio's top competitors include Nanopore, QuantuMDx and Complete Genomics.
Is PacBio publicly traded?
Yes, PacBio is publicly traded on NASDAQ under the ticker symbol PACB.
How many acquisitions has PacBio made?
PacBio has made 2 acquisitions, including Circulomics, and Omniome.
Who are PacBio's investors?
PacBio has 21 investors. Key investors include Morgan Stanley, Kleiner Perkins, SoftBank Group, Blackstone, and AllianceBernstein.
What is PacBio's ticker symbol?
The ticker symbol of PacBio is PACB on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.